iCliniq Logo
HomeHealth articlesMedical oncologycancer

Understanding Brain Tumor Treatment

Verified data
0

7 min read

Share

Outline

Imagine cells in your brain growing out of control; that's brain cancer. Because these cells multiply rapidly, treating them early is crucial.

Medically reviewed byDr. Rajesh Gulati

Published At June 4, 2025
Reviewed AtNovember 7, 2025

Brain Tumor Surgery

For many people diagnosed with a brain tumor, surgery is often the first step in treatment. In some cases, the goal is to remove the cancer entirely. In others, only part of it can be removed, mainly if it’s located near sensitive brain areas. Even partial removal can ease pressure inside the skull, which often helps reduce symptoms like headaches, vision problems, or trouble thinking clearly. Surgery not only helps relieve symptoms but can also make other treatments for brain tumors, like radiation or chemotherapy, more effective.

Understanding the Role of a Biopsy

Surgery for a brain tumor often includes a biopsy, which involves taking a small sample of the tumor to study under a microscope. If complete surgery isn’t possible, for example, if the tumor is in a risky spot, a biopsy alone might be done to get important information. The results help doctors confirm what kind of tumor it is, how aggressive it might be, and what treatment options are best. Sometimes, if a biopsy can’t be performed safely, doctors will use other tests to guide the diagnosis and treatment plan. Biopsy results are also normal to take a week or more, so you may not get a final answer immediately.

Radiation Therapy for Brain Cancer

  • Cancer cells get destroyed by concentrated energy beams during radiation therapy, a treatment often known simply as radiation.

  • Malignant brain tumors and benign ones are usually treated with it as part of a broader treatment plan involving chemotherapy or sometimes surgery.

  • Brain tumors get zapped with radiation therapy mostly via external beam radiation, which blasts tumors from outside using conformal radiotherapy methods.

  • Stereotactic radiosurgery (SRS) involves administering a solitary high-dose radiation treatment squarely targeted at a particular brain region.

  • Stereotactic radiotherapy (SRT) delivers large doses in smaller portions, administered sporadically over several days.

  • In brachytherapy, radioactive seeds are positioned very near tumors for localized treatment. Proton beam therapy delivers radiation via proton beams, significantly reducing harm to surrounding healthy tissue.

  • Brain tumor radiation therapy encompasses various types and treatments for metastatic tumors, often involving whole-brain radiation, exposing the entire brain tissue. Fractionated radiotherapy administers radiation over several weeks in multiple sessions, slowly and sometimes quite intensely.

  • Precise targeting relies heavily on imaging techniques employed during treatment sessions, with image-guided radiotherapy being quite effective.

Chemotherapy for Brain Cancer

  • Chemotherapy for brain cancer involves anticancer drugs, which kill or reduce the growth of tumor cells fairly effectively sometimes. It frequently gets used alongside other forms of therapy like radiation treatment or surgical intervention, and it often has varying degrees of brain tumors treatment.

  • Chemotherapy is administered intravenously or orally, or as a dissolvable wafer during surgery, or straight into cerebrospinal fluid.

  • Chemotherapy medications brutally annihilate or maim cancerous cells, thereby halting their proliferation and division effectively, or so it seems. Medications circulate via the bloodstream, reaching numerous bodily parts, including the brain, very effectively.

  • The blood-brain barrier shields the brain from nasty substances, and some chemo meds may struggle to pass through it relatively slowly, somehow.

  • Chemotherapy is occasionally administered intrathecally, thereby avoiding the blood-brain barrier and entering cerebrospinal fluid directly. Chemotherapy medications are placed directly on tumors during surgery and combined with radiation therapy or used alongside radiation treatments effectively.

  • Temozolomide remains a frequently prescribed medication for anaplastic astrocytomas and glioblastomas in brains that have recently been under intense scrutiny worldwide. Procarbazine, Lomustine, and Vincristine, collectively referred to as PCV, are often used quite effectively for the treatment of brain tumors.

  • Cisplatin plus Bevacizumab may be utilized alternatively in certain situations.

Targeted Drug Therapy for Brain Cancer

Targeted drug therapies offer a more precise approach to brain tumor treatment options. Unlike traditional chemotherapy, which can harm healthy cells along with cancerous ones, targeted therapies work more focused.

They aim at the specific traits or changes found only in cancer cells. By blocking certain proteins or pathways that help the tumor grow, these treatments can slow or stop the cancer, often with fewer side effects than regular chemotherapy.

  • These therapies disrupt key signals or processes cancer cells depend on to survive. For example, they might block blood vessel growth that feeds tumors (a process called angiogenesis) or shut down proteins that help cancer cells multiply.

  • Some targeted drugs are designed for particular tumor types. One example is Vorasidenib, an IDH (isocitrate dehydrogenase) inhibitor that targets abnormal IDH1 and IDH2 proteins often found in certain brain tumors. This drug may help these tumor cells behave more like normal ones.

  • For children with brain tumors that have a BRAF (V-Raf Murine Sarcoma Viral Oncogene Homolog B1) mutation, especially in some low-grade gliomas, Tovorafenib may offer benefits by blocking the BRAF protein, which helps drive the cancer’s growth.

How mRNA Vaccines Are Revolutionizing Brain Cancer Treatment?

  • mRNA (messenger ribonucleic acid) vaccines transform brain cancer treatment by harnessing the body's immune system to target and eliminate cancer cells. Unlike traditional therapies that attack cells indiscriminately, mRNA vaccines offer personalized treatment.

  • They can be tailored specifically for individual patients by encoding particular tumor antigens or neoantigens. When patients' cells receive mRNA with these antigens, they produce them, triggering the immune system to identify and rapidly target cancer cells.

  • mRNA vaccinations amplify antibody production and activate multifaceted immune responses, including humoral and T-cell-mediated immunity. This dual action creates a stronger immune response against glioblastoma cells, potentially leading to significantly enhanced potency and brain tumor treatment success rate.

  • mRNA vaccines can also target tumor microenvironments and inhibit immune system suppression. Furthermore, they can foster T-cells with long-term memory potential, offering persistent defense against cancer recurrence—a significant advantage over standard therapies.

  • Specific mRNA vaccine delivery systems help cross the blood-brain barrier, which often blocks many medications. For example, mRNA can be encapsulated in nanoparticles like lipoplexes and polyplexes for transport into brain tissue.

  • mRNA vaccines can also be used effectively with immunotherapies like checkpoint inhibitors to boost overall effectiveness significantly. This synergistic approach leads to substantially more pronounced tumor shrinkage and improved survival rates.

  • Early-phase clinical trials demonstrated the safety of mRNA vaccines, which also elicited strong immune responses in glioblastoma patients, often within 48 hours of administration.

  • Prospects such as surmounting immunosuppressive tumor microenvironments, bolstering mRNA vaccine stability and scalability, and refining delivery methods present difficulties.

  • Future studies should resolve nagging issues and investigate novel combination therapies for effectively treating brain cancer with mRNA vaccines.

Role of CAR-T Cell Therapy in Combating Brain Tumors:

  • CAR-T (chimeric antigen receptor T-cell) therapy modifies a patient's T cells (lymphocytes) to specifically identify cancerous cells, offering a potential treatment for glioblastoma (abnormal cell growth in the brain or spinal cord) and other brain cancers.

  • In laboratories, T cells are genetically engineered to produce synthetic receptors that target tumor-specific antigens, and these modified cells are then reinfused into patients. While this treatment has shown early success in hematologic cancers, its application to solid tumors like brain tumors has faced difficulties, mainly due to tumor antigen heterogeneity and an immunosuppressive tumor microenvironment.

  • CAR-T cells are intricately engineered to accurately spot specific proteins or antigens on brain tumor cell surfaces. These cells can be delivered directly into brain tissue via injections or other specialized techniques.

  • CAR-T cells then swiftly identify tumor cells and trigger a potent immunological reaction that effectively annihilates cancerous cells. Signaling molecules expressed by CAR-T cells substantially boost their tumor-killing capacity and bolster survival within bodily tissues. However, due to their restrictive nature, CAR-T cells face hurdles crossing the blood-brain barrier to the tumor site. However, CAR-T cell therapy for brain tumors faces challenges:

  • The environment around brain tumors can suppress the immune system, making it hard for CAR-T cells to work well.

  • Brain tumor cells can have different proteins (antigens) on their surface, so one type of CAR-T cell might not target all of them.

  • Tumor cells can change over time, sometimes expressing less of the target antigen, leading to treatment resistance.

Researchers are probing various methods for augmenting CAR-T cell efficacy and developing dual-target CAR-T cells very slowly outside labs. Targeted ultrasound boosts CAR-T cell activation and facilitates their frantic transport effectively under various physiological conditions. Merging CAR-T therapy with various immune checkpoint inhibitors yields intriguing results in some complex cancer treatment protocols, albeit somewhat effectively.

Post-Treatment Care for Brain Tumor Patients

Recovery does not end when treatment does. Aftercare is about helping patients slowly rebuild their strength and adjust to life after treatment. Regular check-ins with doctors and therapists help track progress and spot new concerns early. Many people also need support managing side effects, returning to daily routines, and finding emotional balance. It’s normal to feel overwhelmed, tired, or anxious; having the proper support can make the transition a little easier.

Rehabilitation After Brain Cancer

Rehabilitation plays a vital role in helping brain cancer patients recover lost abilities caused by surgery, chemotherapy, or radiation. Each patient’s needs are different, so that rehab can include a mix of physical, speech, and occupational therapy.

  • Some people receive therapy at the hospital through outpatient programs, while others may receive regular visits at home from trained rehab specialists.

  • Physical therapy aids in regaining strength, balance, and coordination, especially if the tumor affected movement. Occupational therapy helps people return to their daily routines, like dressing, cooking, or returning to work.

  • Speech therapy is helpful when speech or swallowing becomes difficult due to damage in specific brain areas. Cognitive therapy focuses on improving memory, focus, and problem-solving skills that might be affected by the tumor or treatment.

  • Emotional recovery is just as important. Many patients face anxiety, depression, or mood changes, so counseling and mental health support are often included as part of the rehabilitation process.

Conclusion

Brain cancer can profoundly affect how a person thinks, moves, and lives day to day. It’s a complex illness that often requires early diagnosis and a team-based approach using surgery, radiation, and chemotherapy. Thanks to ongoing research, new treatments like personalized medicine and targeted therapy offer more hope than ever. At the same time, supportive care, both physical and emotional, is key to helping patients and families cope with the challenges of brain cancer.

Key Takeaway from iCliniq

Facing a brain cancer diagnosis can be overwhelming physically, mentally, and emotionally. It’s completely normal to feel scared or exhausted. That’s why it’s so important to focus on brain tumor treatment options, emotional support, and managing fatigue along the way. Brain cancer often grows quickly and needs fast, expert attention. iCliniq connects patients with experienced medical professionals who can help with early diagnosis, create personalized treatment plans, and offer supportive care.

Listen to related tracks in our music library

Frequently Asked Questions

Decades of study and massive funding have yielded a negligible change in brain cancer death rates, particularly for glioblastoma patients. Rethinking brain cancer as an aberrant brain-like organ necessitates creative therapeutic approaches utterly different from those used for other tumors. Precision medicine in oncology spawns thorny ethical conundrums and necessitates innovative trial designs for treating brain cancer with specificity. Curative medicine discovery is impeded by age-old paradigms that spur overdiagnosis and overtreatment of cancer as merely a tumorous mass. A paradigm shift might spur rampant collaboration amongst numerous disparate scientific disciplines, addressing brain cancer's labyrinthine complexity with fervor.

Customized treatments are developed quite effectively using monoclonal antibodies based on molecular characteristics of various malignancies nowadays. Investigating biologic response modifiers such as interleukin-2 and interferons effectively increases host reactivity against malignancies beyond immunosuppression. Boosting drug dispersal unevenly improves MA delivery at tumor sites and amplifies MA specificity for supporting unorthodox novel therapeutic approaches. Tumor microenvironment intricacies have been clarified haphazardly, spawning novel effective immunotherapies. Cellular immunotherapies coupled with immune checkpoint inhibitors effectively surmount obstacles posed by the immunosuppressive microenvironment and the blood-brain barrier. Immunomics leverages cutting-edge molecular tools like DNA microarrays to identify brain tumor antigen epitopes and classify patients effectively nowadays.

Tumor samples are taken repeatedly as the disease progresses rapidly, pinpointing molecular processes that underlie stubborn resistance mechanisms that quietly emerge inside tumors. Examining circulating tumor DNA instantly reveals new resistance changes, which may enable early intervention in many cancer patients. Ex vivo preclinical models involve crafting tissue models that meticulously factor in genetic sequencing data, physiological characteristics, and bioadhesive matrix stiffness. Pharmacological evaluation entails testing various drugs on cell lines derived from resistant tumor samples alongside elaborate genetic profiling of those samples. Multifaceted modeling involves creating lab models that replicate various resistance mechanisms like invasiveness, genetic adaptations, and stromal interactions quite effectively nowadays.

Tags:

cancerbrain tumor management

Ask your health query to a doctor online

Medical oncology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.